Filing Details

Accession Number:
0001609351-17-000060
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-21 16:43:51
Reporting Period:
2017-06-19
Filing Date:
2017-06-21
Accepted Time:
2017-06-21 16:43:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609351 Spark Therapeutics Inc. ONCE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1438421 W Stephen Webster C/O Spark Therapeutics, Inc.
3737 Market Street, Suite 1300
Philadelphia PA 19104
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-19 7,663 $3.45 10,163 No 4 M Direct
Common Stock Disposition 2017-06-19 7,663 $60.00 2,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-06-19 7,663 $0.00 7,663 $3.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
128,352 2024-07-07 No 4 M Direct
Footnotes
  1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2017.
  2. This option was granted on July 7, 2014 and vests over four years, with 25% of the shares underlying the option vesting on July 7, 2015, and the remainder vesting quarterly thereafter.